Do the NCEP guidelines point to the use of an expanded lipid panel like the VAP Test?
The NCEP ATP III guidelines offer new opportunities to improve the early detection and treatment of heart disease. ATP III focuses attention on the metabolic syndrome, as well as several emerging risk factors and secondary targets of therapy that are not measured with the routine lipid panel. The VAP Test allows clinicians to comply with ATP III at a cost comparable to the routine lipid panel.